Skip to main content

Dr. Samuel G. Deem, DO

Urology (Urology Physician)

  • Medicare participating

At a glance

Years since graduation
22
In the NPI registry since
2007
Medicare patients seen, 2024
579

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2004Medical school: West Virginia School of Osteopathic Medicine
  • 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Urology Physician primary
    WV license 2176

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Urology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
579
Services billed
1,257
Patients’ average age
74
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 20-29 minutes235204
Established patient office or other outpatient visit, 30-39 minutes217163
Diagnostic exam of bladder and urethra using an endoscope13188
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes10094
New patient office or other outpatient visit, 30-44 minutes4646
New patient office or other outpatient visit, 45-59 minutes4545
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes3922
Ultrasound scan of pelvic region through rectum3329
Established patient office or other outpatient visit, 10-19 minutes3232
Telephone medical discussion with physician, 11-20 minutes2523

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 12 companies reported 24 payments worth $935 in total to this clinician.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in West Virginia →

Industry-funded research

Named as a principal investigator on 6 industry-funded studies in 2025, from 3 companies. The companies reported $121,239 in research payments for these studies, mostly to the institutions running them.

  • A Phase III, Randomized, Double-blind, Matching Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab MK-3475 in Combination With Chemoradiotherapy CRT versus CRT Alone in Participants wi…
    Merck Sharp & Dohme LLC
  • A Randomized Phase 3 Study Evaluating Cystectomy with Perioperative Pembrolizumab and Cystectomy with Perioperative Enfortumab Vedotin and Pembrolizumab versus Cystectomy Alone in Participants who are Cisplatin-Inelig…
    Merck Sharp & Dohme LLC
  • A Phase 3, Randomized Double Blind Study to Evaluate Peri-operative Pembrolizumab MK-3475 Neoadjuvant Chemotherapy versus Perioperative Placebo Neoadjuvant Chemotherapy in Cisplatin-Eligible Participants with Muscle…
    Merck Sharp & Dohme LLC
  • Study name not reported
    Organon Llc
  • A Randomized Double blind Placebo controlled Phase 3 Study of Apalutamide in Subjects with High risk Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy
    Janssen Research & Development, LLC
  • Study name not reported
    Organon Llc

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Urology clinicians in Charleston

Sources

NPI registry (CMS NPPES, November 2026; record last updated December 1, 2025), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1700909702. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.